Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 26, 2012
Adolescent experiences in a vaccine trial: a pilot studyAmber Abrams, Nandi Siegfried, Hennie Geldenhuys
American Journal of Infection Control|February 5, 2013
Knowledge and acceptability of patient-specific infection control measures for pulmonary tuberculosisYulieth Gonzalez-Angulo, Hennie Geldenhuys, Danelle Van As, et al.
The Pediatric Infectious Disease Journal|November 19, 2011
Diagnostic features associated with culture of Mycobacterium tuberculosis among young children in a vaccine trial settingKany Kany A Luabeya, Humphrey Mulenga, Sizulu Moyo, et al.
Vaccine|April 30, 2011
Phenotypic variability in childhood TB: implications for diagnostic endpoints in tuberculosis vaccine trialsHumphrey Mulenga, Sizulu Moyo, Lesley Workman, et al.
The Pediatric Infectious Disease Journal|August 22, 2014
Time to symptom resolution in young children treated for pulmonary tuberculosisNkosilesisa Mpofu, Sizulu Moyo, Humphrey Mulenga, et al.
Bulletin of the World Health Organization|May 1, 2010
Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South AfricaMark Hatherill, Monique Hanslo, Tony Hawkridge, et al.
BMJ Open|March 12, 2017
Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocolErick Wekesa Bunyasi, Bey-Marrie Schmidt, Leila Hussein Abdullahi, et al.
Plos One|February 6, 2014
The candidate TB vaccine, MVA85A, induces highly durable Th1 responsesMichele Tameris, Hennie Geldenhuys, Angelique KanyKany Luabeya, et al.
Plos One|November 12, 2015
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine TrialErick Wekesa Bunyasi, Michele Tameris, Hennie Geldenhuys, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentineSimbarashe P Zvada, Paolo Denti, Hennie Geldenhuys, et al.
Pageof 4